论文信息 - Efficacy and safety of pembrolizumab in relapsed/refractory primary mediastinal large B‐cell lymphoma (rrPMBCL): interim analysis of the KEYNOTE‐170 phase 2 trial - 字舞流文

Efficacy and safety of pembrolizumab in relapsed/refractory primary mediastinal large B‐cell lymphoma (rrPMBCL): interim analysis of the KEYNOTE‐170 phase 2 trial

G. Salles | M. Shipp | P. Zinzani | B. Christian | J. Walewski | C. Thieblemont | A. Balakumaran | K. Bouabdallah | M. Özcan | A. Majlis | L. Fogliatto | S. Chlosta | Z. Gulbaş | D. Osmanov | M. D. Caballero Barrigón | A. Chatterjee | P. Armand | V. Melnichenko